NASDAQ · TECHNOLOGY · Financials
Aehr Test Systems (AEHR) financial statements and cash flow.
Revenue, profitability, balance-sheet strength, and cash generation for AEHR. Market data source · income-statement quarterly · as of 2026-02-28 · Market data source · balance-sheet-statement quarterly · as of 2026-02-28.
Section freshness
Price Jul 15, 4:00 PM EDT · Statements Feb 27, 7:00 PM EST
Source timingDetailsHide
Data freshness
Prices update fastest. Fundamentals, analyst data, and news update on their own schedules, so check these timestamps before comparing signals.
Price time means the latest available trade or regular-market close. Other times show when that section was checked or published.
Financial read
AEHR latest financial snapshot.
Start with the latest revenue, net income, free cash flow, and margin profile. Deeper quarterly and annual statement tables follow below.
Revenue
$10.31M
-43.7% YoY
Net income
-$3.20M
+0.8% QoQ
Free cash flow
-$2.93M
-58.0% QoQ
Gross margin
32.66%
Gross profit $3.37M
Balance sheet coverage
AEHR balance sheet summary
Assets, liabilities, liquidity, debt, and equity sit beside income and cash-flow tables so the statement history reads as one model-ready dataset.
81 quarterly · 20 annual rows · Market data source · balance-sheet-statement quarterly · as of 2026-02-28
Latest period
Q1 FY2026
81 quarterly · 20 annual rows
Assets / liabilities
$157.05M
Liabilities $18.25M
Cash / debt
$36.91M
Net cash $26.89M
Equity / working capital
$138.79M
Working capital $87.16M
Financial statements
AEHR statement coverage.
Income statement, balance sheet, and cash-flow figures for AEHR, with quarterly and annual history in the tables below.
Data last updated
Feb 27, 2026
Income periods
101
Balance-sheet periods
101
Cash-flow periods
101
Quarterly and annual AEHR statements, sourced from Market data source · income-statement quarterly · as of 2026-02-28 · Market data source · balance-sheet-statement quarterly · as of 2026-02-28.
Financial statement period
AEHR statement history
Market data source · income-statement quarterly · as of 2026-02-28 · Market data source · balance-sheet-statement quarterly · as of 2026-02-28 · Data last updated: Feb 27, 2026
Income statement
Quarterly and annual rows for revenue, operating leverage, earnings quality, and margin direction.
| Period | Revenue | Gross profit | Operating income | Interest income | Continuing ops | Net income | Comprehensive income | Net margin | Revenue QoQ | Net income QoQ |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | $10.31M | $3.37M | -$4.23M | $240,000 | -$3.20M | -$3.20M | — | -31.06% | +4.3% | +0.8% |
| Q4 FY2025 | $9.88M | $2.54M | -$4.87M | $194,000 | -$3.23M | -$3.23M | — | -32.68% | -9.9% | -55.0% |
| Q3 FY2025 | $10.97M | $3.72M | -$4.07M | $179,000 | -$2.08M | -$2.08M | — | -19.00% | -22.1% | +28.1% |
| Q2 FY2025 | $14.09M | $4.27M | -$2.34M | $222,000 | -$2.90M | -$2.90M | — | -20.58% | -23.0% | -350.9% |
| Q1 FY2025 | $18.31M | $7.18M | -$1.12M | $270,000 | -$643,000 | -$643,000 | — | -3.51% | +36.1% | +37.5% |
| Q4 FY2024 | $13.45M | $5.40M | -$1.51M | $228,000 | -$1.03M | -$1.03M | — | -7.64% | +2.5% | -255.8% |
| Q3 FY2024 | $13.12M | $7.08M | $159,000 | $681,000 | $660,000 | $660,000 | — | 5.03% | -21.0% | -97.2% |
| Q2 FY2024 | $16.60M | $8.45M | $2.54M | $592,000 | $23.86M | $23.86M | — | 143.76% | +119.5% | +1722.3% |
Balance sheet
Balance-sheet history for assets, liabilities, liquidity, debt, equity, and shares outstanding.
| Period | Cash | Current assets | Current liabilities | Total assets | Total liabilities | Total debt | Capital leases | Total equity | Shares | Debt QoQ |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | $36.91M | $95.90M | $8.74M | $157.05M | $18.25M | $10.03M | $10.03M | $138.79M | 30.70M | -1.4% |
| Q4 FY2025 | $30.84M | $88.19M | $8.30M | $148.73M | $17.96M | $10.16M | $10.16M | $130.78M | 30.05M | -4.3% |
| Q3 FY2025 | $22.71M | $84.05M | $11.91M | $144.09M | $21.70M | $10.62M | $10.62M | $122.39M | 29.92M | -2.0% |
| Q2 FY2025 | $25.23M | $88.78M | $15.64M | $148.51M | $25.64M | $10.83M | $10.83M | $122.87M | 29.82M | +68.2% |
| Q1 FY2025 | $30.11M | $91.70M | $16.06M | $145.61M | $21.40M | $6.44M | $6.44M | $124.21M | 29.73M | +0.1% |
| Q4 FY2024 | $33.07M | $88.52M | $11.72M | $142.28M | $19.10M | $6.43M | $6.43M | $123.18M | 29.66M | -4.1% |
| Q3 FY2024 | $37.83M | $92.92M | $15.42M | $145.86M | $23.38M | $6.71M | $6.71M | $122.48M | 29.63M | +8.2% |
| Q2 FY2024 | $49.16M | $97.85M | $10.51M | $127.91M | $16.32M | $6.20M | $6.20M | $111.59M | 29.46M | -1.7% |
Cash flow
Operating cash generation, capital expenditure, free cash flow, buybacks, dividends, and cash movement.
| Period | Operating cash flow | CapEx | Free cash flow | Net income | Stock comp | Debt issuance | Dividends paid | Buybacks | Change in cash | FCF QoQ |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | -$2.85M | $74,000 | -$2.93M | -$3.20M | -$287,000 | — | — | -$454,000 | — | -58.0% |
| Q4 FY2025 | -$1.39M | $467,000 | -$1.85M | -$3.23M | $3.51M | — | — | -$491,000 | — | -10.8% |
| Q3 FY2025 | -$282,000 | $1.39M | -$1.67M | -$2.08M | $1.67M | — | — | -$328,000 | — | +67.3% |
| Q2 FY2025 | -$2.30M | $2.82M | -$5.12M | -$2.90M | $1.42M | — | — | -$264,000 | — | -57.0% |
| Q1 FY2025 | -$1.60M | $1.66M | -$3.26M | -$643,000 | $1.80M | — | — | -$177,000 | — | +47.4% |
| Q4 FY2024 | -$5.87M | $321,000 | -$6.19M | -$1.03M | $1.07M | — | — | -$181,000 | — | -383.7% |
| Q3 FY2024 | $2.38M | $197,000 | $2.18M | $660,000 | $870,000 | — | — | -$162,000 | — | +85.3% |
| Q2 FY2024 | $1.22M | $46,000 | $1.18M | $23.86M | $774,000 | — | — | -$116,000 | — | +138.2% |
Valuation and returns
- Enterprise value
- $2.26B
- Market data source · key-metrics-ttm.enterpriseValueTTM
- Return on equity
- -8.68%
- Market data source · ratios-ttm.returnOnEquityTTM
- Return on assets
- -6.10%
- Market data source · ratios-ttm.returnOnAssetsTTM
- Debt / equity
- 0.07
- Current ratio 10.97
Ratio values use provider-attributed fields when available and otherwise fall back to TECHi statement math from the visible rows on this page.
Annual revenue and income multiples
Annual sales and income multiple reads use the latest annual statement when available, then fall back to trailing-twelve-month statement math from the visible quarterly rows.
- Annual revenue base
- $58.97M
- Annual statement 2025-05-31
- Annual income base
- -$3.91M
- Annual statement 2025-05-31
- Market cap / annual revenue
- 46.83
- Live market value divided by annual revenue
- Market cap / annual income
- Not available yet
- Market-cap income multiple not available yet.
Annual sales and income multiple
Market capitalization bridge
TTM valuation multiples
- TTM revenue
- $45.26M
- Trailing twelve months
- TTM EBIT
- -$15.50M
- TTM operating income
- Market cap / TTM revenue
- 61.02
- Live market value divided by trailing twelve months revenue
- EV / TTM revenue
- 49.87
- Enterprise value divided by trailing twelve months revenue
Live market value is matched against trailing-twelve-month statement bases first so the multiple moves with the tape instead of anchoring to stale fiscal-year rows.
Profit multiples
Interest burden
Latest quarter
Uses absolute annual net income when positive or negative
Revenue, net income, and free cash flow
Quarterly statement rows, shown on one common dollar scale so margin compression and cash conversion stand out quickly.
Efficiency
- Revenue / employee
- Pending
- Employee count pending
- Net income / employee
- Pending
- TTM net income divided by employees
- FCF / employee
- Pending
- TTM free cash flow divided by employees
- Market cap / employee
- Pending
- Live value per employee
Growth vs cost pressure
Cash conversion
TTM free cash flow / TTM operating income
TTM operating cash flow / TTM EBITDA
Quarterly margin heatmap
Latest quarter expense mix
Profit bridge
Detailed income lines
Other income statement lines
Balance sheet · Q1 FY2026
- Cash & equivalents
- $36.91M
- Total debt
- $10.03M
- Net cash
- $26.89M
- Net cash position
- Total equity
- $138.79M
Balance sheet detail
- Current assets
- $95.90M
- Current liabilities
- $8.74M
- Inventory
- $41.16M
- Receivables
- $11.81M
- Property, plant & equipment
- $18.37M
- Current debt
- $606,000
- Shares outstanding
- 30.70M
Balance sheet assets detail
Balance sheet liabilities detail
Debt and liquidity
Operating income / interest expense
Cash + short-term investments + receivables / current liabilities
Shares outstanding trend
Quarterly balance-sheet shares outstanding, useful for spotting buybacks, dilution, and split-adjusted share-count drift.
Cash generation
- Operating cash flow
- -$2.85M
- Capital expenditure
- $74,000
- Free cash flow
- -$2.93M
- Capital returned
- -$454,000
- Buybacks + dividends paid
Cash-flow detail
- Depreciation & amortization
- $860,000
- Investing cash flow
- -$74,000
- Financing cash flow
- $9.83M
- Change in inventory
- $857,000
- Buybacks
- -$454,000
- Net buybacks
- -$454,000
- Repurchases less stock issuance
Cash flow read
AEHR is consuming cash this period.
Negative free cash flow can be deliberate (heavy capex on a growth project) or stress (operating cash flow turning south). Compare -$2.85M of operating cash flow against $74,000 of capex to see which side is moving.
Frequently asked
Common questions.
Where can I see AEHR financial statements?
The AEHR Financials page hosts the latest income statement, balance sheet, and cash-flow statement for Aehr Test Systems — quarterly and annual views, with TECHi's source attribution next to every line.
What is Aehr Test Systems's revenue trend?
Quarterly and annual revenue, gross profit, operating income, net income, and free-cash-flow trends for Aehr Test Systems are shown in the AEHR Financials page visuals and statement tables when provider data supplies complete rows.
What is Aehr Test Systems's profit margin?
Aehr Test Systems reports a net margin of -25.20%. Gross / operating / net margin trends and the segment mix that drives them are broken out on the AEHR Financials page.
Does Aehr Test Systems have positive free cash flow?
Operating cash flow, capital expenditure, and free cash flow are tracked quarterly on the AEHR Financials page when cash-flow rows are available. FCF margin and FCF yield are normalized on the AEHR Statistics page.